Key result
Angiopoietin-1 prevented AGE-induced vascular leakage and protected endothelial cells from death by enhancing adherens junctions and regulating PI3K/Akt-dependent Bad phosphorylation.
Why the study?
Does Angiopoietin-1 protect endothelial cells against advanced glycation end product injury?
Does Angiopoietin-1 protect endothelial cells against advanced glycation end product injury?
Angiopoietin-1 protects endothelial cells from advanced glycation end product-induced injury by strengthening cell junctions and inhibiting apoptosis, highlighting a potential mechanism to prevent diabetic vasculopathy.
Answers are grounded in this paper and cite their sources.
May protect against diabetic endothelial injury in animal models; leaves open translation to human therapy.
Endothelial dysfunction is a major characteristic of diabetic vasculopathy. Protection of the vascular endothelium is an essential aspect of preventing and treating diabetic vascular complications. Although Angiopoietin-1 (Ang-1) is an important endothelial-specific protective factor, whether Ang-1 protects vascular cells undergoing advanced glycation end product (AGE) injury has not been investigated. The aim of the present study was to determine the potential effects of Ang-1 on endothelial cells after exposure to AGE. We show here that Ang-1 prevented AGE-induced vascular leakage by enhancing the adherens junctions between endothelial cells, and this process was mediated by the phosphorylation and membrane localization of VE-cadherin. Furthermore, Ang-1 also protected endothelial cells from AGE-induced death by regulating phosphatidylinositol 3-kinase (PI3K)/Akt-dependent Bad phosphorylation. Our findings suggest that the novel protective mechanisms of Ang-1 on endothelium are achieved by strengthening endothelial cell junctions and reducing endothelial cell death after AGE injury.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2014) studied Diabetic vasculopathy / Advanced glycation end product (AGE) injury. Angiopoietin-1 (Ang-1) was evaluated on AGE-induced vascular leakage and endothelial cell death. Angiopoietin-1 prevented AGE-induced vascular leakage and protected endothelial cells from death by enhancing adherens junctions and regulating PI3K/Akt-dependent Bad phosphorylation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: